AM-9022

N/A

Report date: 2024/03/22 16:54:51

NME

Base Information

Drug NameAM-9022

Drug Alias NameAM-9022

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionKinesin-like protein KIF18A inhibitors

TargetsKinesin-like protein KIF18A

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAmgen Research Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A